Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
申请人:ALCASYNN PHARMACEUTICALS GMBH
公开号:EP1595541A1
公开(公告)日:2005-11-16
Morphinane derivatives of the formula
their pharmaceutically acceptable salts are provided for use as medicaments for the treatment and/or prevention of disorders associated with the target calcineurin.